English  |  正體中文  |  简体中文  |  Items with full text/Total items : 12145/12927 (94%)
Visitors : 856852      Online Users : 938
RC Version 6.0 © Powered By DSPACE, MIT. Enhanced by NTU Library IR team.
Scope Tips:
  • please add "double quotation mark" for query phrases to get precise results
  • please goto advance search for comprehansive author search
    •  Adv. Search
    Home ‧ Login ‧ Upload ‧ Help ‧ About ‧ Administer Goto mobile version


    Please use this identifier to cite or link to this item: http://ir.nhri.org.tw/handle/3990099045/12624


    Title: Multicentre study of risk factors for mortality in patients with acinetobacter bacteraemia receiving colistin treatment
    Authors: Lee, YT;Sun, JR;Wang, YC;Chiu, CH;Kuo, SC;Chen, TL;Yang, YS
    Contributors: National Institute of Infectious Diseases and Vaccinology
    Abstract: Colistin remains a last-line antibiotic for the treatment of multi-drug-resistant Acinetobacter species. However, mortality rates are high in patients with Acinetobacter infection receiving colistin treatment. This multi-center study evaluated whether colistin susceptibility, additional antimicrobial agents, or other prognostic factors influenced the clinical outcomes of patients receiving colistin treatment for Acinetobacter bacteremia. This retrospective study enrolled 122 adults receiving colistin treatment for monomicrobial Acinetobacter bacteremia at six medical centers over 8 years. Clinical information, antimicrobial susceptibility, and colistin resistance determinants were analysed. The primary outcome measure was 14-day mortality. Among 122 patients, 18 and 104 were infected with colistin-resistant (ColR) isolates (minimal inhibitory concentrations [MICs] >/=4 mg/L) and colistin-susceptible (ColS) isolates (MICs </=2 mg/L), respectively. Patients infected with ColR and ColS isolates were not significantly different in Charlson comorbidity index, invasive procedures, sources of bacteremia, disease severity, and 14-day mortality rates (44.4% vs. 34.6%, P=0.592). No specific additional antimicrobial agent was independently associated with higher or lower mortality. Coronary artery disease, higher APACHE II score, and bacteremia caused by A. baumannii were independent risk factors associated with 14-day mortality. The mechanisms of colistin resistance were associated with amino acid variants in the pmrCAB operon. Finally, we identified previously unreported A. nosocomialis amino acid variants related to colistin resistance. In conclusion, colistin susceptibility and colistin combination antimicrobial treatment were not associated with decreased 14-day mortality in patients with Acinetobacter bacteremia receiving colistin treatment.
    Date: 2020-06
    Relation: International Journal of Antimicrobial Agents. 2020 Jun;55(6):Article number 105956.
    Link to: http://dx.doi.org/10.1016/j.ijantimicag.2020.105956
    JIF/Ranking 2023: http://gateway.webofknowledge.com/gateway/Gateway.cgi?GWVersion=2&SrcAuth=NHRI&SrcApp=NHRI_IR&KeyISSN=0924-8579&DestApp=IC2JCR
    Cited Times(WOS): https://www.webofscience.com/wos/woscc/full-record/WOS:000545310600010
    Cited Times(Scopus): https://www.scopus.com/inward/record.url?partnerID=HzOxMe3b&scp=85085105150
    Appears in Collections:[郭書辰] 期刊論文

    Files in This Item:

    File Description SizeFormat
    PUB32278810.pdf589KbAdobe PDF211View/Open


    All items in NHRI are protected by copyright, with all rights reserved.

    Related Items in TAIR

    DSpace Software Copyright © 2002-2004  MIT &  Hewlett-Packard  /   Enhanced by   NTU Library IR team Copyright ©   - Feedback